The services of the Division of Respirology encompass the assessment and management of the following patient populations:

• The second largest cystic fibrosis (CF) clinic in Ontario
• One of five Ontario newborn screening clinics for cystic fibrosis
• Cystic fibrosis-screen positive indeterminate diagnosis clinic
• Non-invasive ventilation
• Sickle cell disease-related lung disease
• Primary ciliary dyskinesia
• Bronchopulmonary dysplasia
• General respirology conditions
• Difficult to treat asthma
• Sleep disordered breathing
• Aerodigestive disease

• Development of a transition program for cystic fibrosis (CF) patients, with teaching materials
• In the process of outlining a transition program through developmental age groups for CF
• RSV and CF collaboration to immunize all CF patients < 1 year
• Oral glucose tolerance test (OGTT) as an outpatient using specimen collection centre and decreased use of medical daycare
• CF admission order set
• CF infection control policy that meets the standard of care guidelines for CF across Canada
• Securing access to a compassionate supply of the newest gene modulator therapy that is not available in Canada for pediatric patient
• Collaborative care models such as:
  • Joint complex care/respirology ventilation clinic
  • Joint sickle cell disease/respirology clinic
  • Sleep medicine services at the St. Joseph’s Healthcare Hamilton
• New sleep medicine clinics

• Effect of exercise on inflammation in chronic pediatric patients with cystic fibrosis (CF)
• Metabolomics – sweat & stratification of NBS patient and long-term outcomes
• NBS / CF-SPID – long-term clinical implications /outcomes
• Canadian CF database
• Inflammatory changes in the gut while on gene modulator therapy
• Mental health and chronic disease
• Gene modulator therapy and outcomes
• Ventilation and use of technology in the pediatric population
• Exercise physiology in sickle cell disease
• Central sleep apnea in the pediatric population